Ting-Yan Chan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
It has been previously reported that a higher erythropoiesis stimulating agent (ESA) dose in hemodialysis patients is associated with adverse outcomes including mortality; however the causal relationship between ESA and mortality is still hotly debated. We hypothesize ESA dose indeed exhibits a direct linear relationship with mortality in models of(More)
  • 1